Co-Diagnostics (FRA:C97) Total Operating Expense : €38.15 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Co-Diagnostics Total Operating Expense?

Co-Diagnostics's Total Operating Expense for the three months ended in Mar. 2025 was €7.94 Mil. Co-Diagnostics's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was €38.15 Mil.

Co-Diagnostics Total Operating Expense Historical Data

The historical data trend for Co-Diagnostics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Co-Diagnostics Total Operating Expense Chart

Co-Diagnostics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Operating Expense

Get a 7-Day Free Trial

13.37

35.62

38.07

41.57

41.06

Co-Diagnostics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Operating Expense	Get a 7-Day Free Trial															9.46	9.41	9.53	11.27	7.94

Co-Diagnostics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €38.15 Mil.

Co-Diagnostics Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Co-Diagnostics's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Co-Diagnostics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Co-Diagnostics Inc (FRA:C97) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

CODX:USA 0A50:UK C97:Germany

Address

2401 South Foothill Drive, Salt Lake City, UT, USA, 84109

Website

https://www.codiagnostics.com

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Co-Diagnostics Headlines

No Headlines